Novozymes A/S
NVZMY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $113 | $103 | $98 | $151 |
| - Cash | $0 | $1 | $1 | $1 |
| + Debt | $2 | $8 | $0 | $0 |
| Enterprise Value | $115 | $110 | $97 | $151 |
| Revenue | $4 | $18 | $18 | $15 |
| % Growth | -78.6% | 2% | 17.4% | – |
| Gross Profit | $2 | $10 | $10 | $9 |
| % Margin | 47.2% | 54.3% | 54.6% | 57.7% |
| EBITDA | $8 | $5 | $6 | $5 |
| % Margin | 210.5% | 30.6% | 34.8% | 36.1% |
| Net Income | $0 | $3 | $4 | $3 |
| % Margin | 8% | 16.9% | 20.9% | 21% |
| EPS Diluted | 1.1 | 1.46 | 13.19 | 11.23 |
| % Growth | -24.7% | -88.9% | 17.5% | – |
| Operating Cash Flow | $1 | $4 | $4 | $4 |
| Capital Expenditures | -$0 | -$2 | -$3 | -$1 |
| Free Cash Flow | $1 | $2 | $1 | $3 |